Evidence map›Paper›PMID 28502947›Full record

ArticleInternal medicine (Tokyo, Japan)2017

Intractable Cutaneous Nontuberculous Mycobacteriosis (Mycobacterium abscessus) during Treatment for Systemic Lupus Erythematosus.

Dai Kishida, Mitsuto Sato, Chinatsu Kobayashi, Ken-Ichi Ueno, Tomomi Kinoshita, Minori Kodaira, Yasuhiro Shimojima, Wataru Ishii, Atsuhito Ushiki, Shu-Ichi Ikeda

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Dai KishidaDepartment of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, Japan.
Mitsuto SatoDepartment of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, Japan.
Chinatsu KobayashiDepartment of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, Japan.
Ken-Ichi UenoDepartment of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, Japan.
Tomomi KinoshitaDepartment of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, Japan.
Minori KodairaDepartment of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, Japan.
Yasuhiro ShimojimaDepartment of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, Japan.
Wataru IshiiDepartment of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, Japan.
Atsuhito UshikiFirst Department of Internal Medicine, Shinshu University School of Medicine, Japan.
Shu-Ichi IkedaDepartment of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, Japan.
Shinshu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycobacterium abscessus infection tends to occur in patients with an advanced immunocompromised status. We encountered a case of intractable cutaneous M. abscessus infection that developed in a patient with systemic lupus erythematosus (SLE) during maintenance therapy. A 28-year-old woman developed a fever and redness of the skin on her buttocks. General antibacterial therapy was ineffective, and acid-fast bacteria were detected in the biopsy that was conducted to differentiate the dermal symptoms of SLE. The clinical findings eventually improved; however, the symptoms recurred multiple times during treatment. Despite recent advances in SLE treatment, M. abscessus infection remains a considerable complication of SLE.

Indexed as

AdultAnti-Bacterial AgentsClarithromycinFemaleHumansImmunocompromised HostLupus Erythematosus, SystemicMycobacterium Infections, NontuberculousNontuberculous MycobacteriaTreatment OutcomeAnti-Bacterial AgentsClarithromycinclarithromycincutaneous lesionMycobacterium abscessusresistancesystemic lupus erythematosus

Identifiers

PMID28502947
PMCPMC5491827
OpenAlexW2612004127

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.